Nothing Special   »   [go: up one dir, main page]

BE868882A - HALOGENOMETHYL DERIVATIVES OF ALPHA-AMINOACIDS, THEIR PREPARATION AND THEIR THERAPEUTIC USES - Google Patents

HALOGENOMETHYL DERIVATIVES OF ALPHA-AMINOACIDS, THEIR PREPARATION AND THEIR THERAPEUTIC USES

Info

Publication number
BE868882A
BE868882A BE189191A BE189191A BE868882A BE 868882 A BE868882 A BE 868882A BE 189191 A BE189191 A BE 189191A BE 189191 A BE189191 A BE 189191A BE 868882 A BE868882 A BE 868882A
Authority
BE
Belgium
Prior art keywords
aminoacids
alpha
preparation
therapeutic uses
halogenomethyl
Prior art date
Application number
BE189191A
Other languages
French (fr)
Original Assignee
Merrell Toraude & Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Toraude & Co filed Critical Merrell Toraude & Co
Publication of BE868882A publication Critical patent/BE868882A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D211/72—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D211/74—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D211/72—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D211/74—Oxygen atoms
    • C07D211/76—Oxygen atoms attached in position 2 or 6
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/02—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D223/06—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom not condensed with other rings with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D223/08—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06191—Dipeptides containing heteroatoms different from O, S, or N
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Epidemiology (AREA)
  • Biotechnology (AREA)
  • Reproductive Health (AREA)
  • Urology & Nephrology (AREA)
  • Communicable Diseases (AREA)
  • Endocrinology (AREA)
  • Oncology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
BE189191A 1977-07-11 1978-07-10 HALOGENOMETHYL DERIVATIVES OF ALPHA-AMINOACIDS, THEIR PREPARATION AND THEIR THERAPEUTIC USES BE868882A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US81476577A 1977-07-11 1977-07-11
US2875779A 1979-04-10 1979-04-10
US2875879A 1979-04-10 1979-04-10

Publications (1)

Publication Number Publication Date
BE868882A true BE868882A (en) 1978-11-03

Family

ID=27363337

Family Applications (3)

Application Number Title Priority Date Filing Date
BE189191A BE868882A (en) 1977-07-11 1978-07-10 HALOGENOMETHYL DERIVATIVES OF ALPHA-AMINOACIDS, THEIR PREPARATION AND THEIR THERAPEUTIC USES
BE0/199012A BE881209A (en) 1977-07-11 1980-01-17 PHARMACEUTICAL COMPOSITION FOR CONTROLLING TUMOR GROWTH RATE AND METHOD OF USING SAME
BE0/199011A BE881208A (en) 1977-07-11 1980-01-17 PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF PSORIASIS AND METHOD OF USE THEREOF

Family Applications After (2)

Application Number Title Priority Date Filing Date
BE0/199012A BE881209A (en) 1977-07-11 1980-01-17 PHARMACEUTICAL COMPOSITION FOR CONTROLLING TUMOR GROWTH RATE AND METHOD OF USING SAME
BE0/199011A BE881208A (en) 1977-07-11 1980-01-17 PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF PSORIASIS AND METHOD OF USE THEREOF

Country Status (9)

Country Link
JP (1) JPS5419913A (en)
AU (1) AU522660B2 (en)
BE (3) BE868882A (en)
CA (1) CA1091661A (en)
CH (1) CH642055A5 (en)
DE (1) DE2828739A1 (en)
FR (1) FR2430418A1 (en)
GB (1) GB2001960B (en)
NL (2) NL190662C (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4399151A (en) 1980-06-16 1983-08-16 Merrell Dow Pharmaceuticals Inc. Method of inhibiting the growth of protozoa
US4437873A (en) 1981-03-23 1984-03-20 Merrell Dow Pharmaceuticals Inc. Method of inhibiting algae
US6103220A (en) * 1998-01-23 2000-08-15 Levine; Martin Lysine decarboxylase inhibitors for the prevention and treatment of periodontal disease
US6187296B1 (en) 1998-01-23 2001-02-13 The Board Of Regents Of The University Of Oklahoma Lysine decarboxylase inhibitors for the prevention and treatment of periodontal disease

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE460517B (en) 1980-06-16 1989-10-23 Merrell Pharma Inc USE OF A COMPOSITION FOR THE PREPARATION OF A MEDICINE FOR THE TREATMENT OF INFECTIONS CAUSED BY TRYPANOSOMA BRUCEI
ZA815808B (en) * 1980-08-23 1982-08-25 Merrell Toraude & Co Fluorinated pentene diamine derivatives
GB2083030B (en) * 1980-08-23 1984-03-07 Merrell Toraude & Co Fluorinated pentene diamine derivatives
US4446151A (en) * 1981-08-19 1984-05-01 Merrell Toraude Et Compagnie Decarboxylase-inhibiting fluorinated pentane diamine derivatives
US4423073A (en) * 1981-08-19 1983-12-27 Merrell Toraude Et Compagnie Fluorinated diaminopentene derivatives
US4435425A (en) 1982-04-09 1984-03-06 Merrell Toraude Et Compagnie Fluorinated diaminobutane derivatives
JPS62148462A (en) * 1985-12-19 1987-07-02 メレルダウフア−マス−テイカルズ　インコ−ポレ−テツド Novel method of controlling growth of protozoa
ATE77367T1 (en) * 1988-02-05 1992-07-15 Merrell Dow Pharma 5-SUBSTITUTED ORNITHINE DERIVATIVES.
CA1319123C (en) * 1988-08-31 1993-06-15 Andrew T. Au Method for the production of (-) 2-substituted-ornithines
US7015349B2 (en) * 2003-03-26 2006-03-21 The Gillette Company Reduction of hair growth
US20230218644A1 (en) 2020-04-16 2023-07-13 Som Innovation Biotech, S.A. Compounds for use in the treatment of viral infections by respiratory syndrome-related coronavirus

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GR64495B (en) * 1977-06-01 1980-03-31 Merck & Co Inc Novel fluorinated amino acids

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4399151A (en) 1980-06-16 1983-08-16 Merrell Dow Pharmaceuticals Inc. Method of inhibiting the growth of protozoa
US4437873A (en) 1981-03-23 1984-03-20 Merrell Dow Pharmaceuticals Inc. Method of inhibiting algae
US6103220A (en) * 1998-01-23 2000-08-15 Levine; Martin Lysine decarboxylase inhibitors for the prevention and treatment of periodontal disease
US6187296B1 (en) 1998-01-23 2001-02-13 The Board Of Regents Of The University Of Oklahoma Lysine decarboxylase inhibitors for the prevention and treatment of periodontal disease

Also Published As

Publication number Publication date
JPS5419913A (en) 1979-02-15
DE2828739A1 (en) 1979-02-01
JPH0122259B2 (en) 1989-04-25
AU522660B2 (en) 1982-06-17
AU3732778A (en) 1980-01-03
NL190662B (en) 1994-01-17
FR2430418B1 (en) 1984-07-13
NL950027I1 (en) 1996-02-01
BE881208A (en) 1980-05-16
GB2001960A (en) 1979-02-14
CH642055A5 (en) 1984-03-30
NL7807453A (en) 1979-01-15
NL950027I2 (en) 1997-06-02
FR2430418A1 (en) 1980-02-01
CA1091661A (en) 1980-12-16
NL190662C (en) 1994-06-16
BE881209A (en) 1980-05-16
GB2001960B (en) 1982-02-24

Similar Documents

Publication Publication Date Title
BE889930A (en) INDOLE DERIVATIVES, THEIR PREPARATION AND THERAPEUTIC USES
BE887800A (en) CARBOSTYRILE DERIVATIVES, PREPARATION METHODS THEREOF AND THERAPEUTIC APPLICATION THEREOF
BE890024A (en) TRICYCLIC IMIDAZOLE DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC USES
BE889929A (en) INDOLE DERIVATIVES, THEIR PREPARATION AND THERAPEUTIC USES
BE849196A (en) ARGININAMIDE DERIVATIVES, THEIR PREPARATION AND THERAPEUTIC USE
BE868882A (en) HALOGENOMETHYL DERIVATIVES OF ALPHA-AMINOACIDS, THEIR PREPARATION AND THEIR THERAPEUTIC USES
BE841537A (en) AMINOALCANOLS MIXTURES, THEIR PREPARATION AND THEIR USES
BE882764A (en) PENEME-3-CARBOXYLIC ACID DERIVATIVES, PREPARATION METHODS THEREOF AND THERAPEUTIC APPLICATION THEREOF
BE843679A (en) 16,16-SPIROCYCLOALKYLPROSTAGLANDIN DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC USES
BE845271A (en) NEW DERIVATIVES OF AMINO-4 QUINOLEINE, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATIONS
FR2330404A1 (en) 1,4-DIAZEPINE DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC USES
BE859613A (en) STEROID DERIVATIVES THEIR PREPARATION AND THERAPEUTIC USES
BE839362A (en) L- (3,4-DIHYDROXY-PHENYL) -2-METHYL-ALKALINE DERIVATIVES AND THEIR PREPARATION
BE857576A (en) PHENOTHIAZINE DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC USES
BE864484A (en) BENZYLPYRIDIMINES, THEIR PREPARATION AND THEIR THERAPEUTIC USES
BE841536A (en) AMINOALCANOLS MIXTURES, THEIR PREPARATION AND THEIR USES
BE871857A (en) NEW DISUBSTITLED PIPERAZINES, THEIR METHODS OF PREPARATION AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
FR2318853A1 (en) DODECATETRAENE DERIVATIVES, THEIR PREPARATION AND THEIR USES
MC1344A1 (en) PYRROLIDINE DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC USES
FR2398753B1 (en) PYRANOCHROMONE DERIVATIVES AND THEIR THERAPEUTIC APPLICATION
BE869177A (en) HALOGENOMETHYL DERIVATIVES OF AMINOACIDS, THEIR PREPARATION AND USE
BE868570A (en) TETRANAPHTALENESULPHONIC ACID DERIVATIVES, THEIR PREPARATION AND THERAPEUTIC USES
BE846117A (en) DERIVATIVES OF 1-OXO-ISOINDOLINE, THEIR METHODS OF PREPARATION AND THEIR APPLICATION
BE868569A (en) DIPHENYL DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC USES
BE859213A (en) PYRIDOBENZODIAZEPINONES, THEIR PREPARATION AND THEIR THERAPEUTIC USES

Legal Events

Date Code Title Description
CCPA Application for a supplementary protection certificate

Free format text: 093C0166

CN Change of patent owner's name
RE Patent lapsed

Owner name: MARION MERRELL DOW ET CIE

Effective date: 19930731